A new strain of bird flu appears to retain its ability to cause serious disease even after it develops resistance to anti-viral drugs, U.S. researchers say. Dr. Nicole Bouvier, an assistant professor of medicine, infectious diseases at ...
Tags: strain of bird flu, avian influenza strains, influenza, H7N9
Tempur Sealy International employees are participating in A Day of Sleep symposium here today designed to give them insights into the latest developments in sleep science. The program is part of a partnership between the bedding producer ...
Tags: Tempur Sealy, sleep science, bedding, sleep clinicians
Although the flu vaccine's effectiveness is less than 100 percent, U.S. health officials say there would be less sickness if more adults were vaccinated. Officials at the Centers for Disease Control and Prevention said although the flu ...
A study says 1-in-4 U.S. adults reports feeling "extreme stress" this time of year, but a childhood expert suggests ways to develop holiday resilience. Nefertiti Bruce, early childhood specialist and national trainer at the Devereux ...
Boys who left school or college during a recession experienced better health later in life than if they left in a boom, but not girls, British researchers say. Philipp Hessel and Mauricio Avendano of London School of Economics Health said ...
The U.S. Department of Health and Human Services says it has taken steps to give those buying individual health insurance for Jan. 1 coverage. Kathleen Sebelius, secretary of HHS, says the steps include requiring insurers to accept ...
Tags: Health, Medicine, health insurance
The U.S. Food and Drug Administration has allowed marketing of the Cerena Transcranial Magnetic Stimulator, a device to relieve pain caused by migraines. Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for ...
U.S. allergists say a new long-term medication in under-the-tongue tablet form is promising and may even have the potential to cure hay fever. Officials at the American Academy of Allergy, Asthma & Immunology said allergy immunotherapy is ...
A meta-analysis found exercise may be as effective as drugs in helping patients with strokes, diabetes and heart disease, British and U.S. researchers say. Researchers at the London School of Economics and Political Science, the Harvard ...
The U.S. Food and Drug Administration approved the first generic versions of Cymbalta, a drug used to treat depression and other conditions, officials say. Dr. Kathleen Uhl, acting director of the Office of Generic Drugs in the FDA's ...
BioWa, a wholly owned subsidiary of Kyowa Hakko Kirin, and Lonza, a biotechnology company, have entered into a licensing agreement with MedImmune, the global biologics research and development arm of AstraZeneca. MedImmune has licensed ...
Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...
Sutro Biopharma has received $26m in a Series D financing, which will be used for the expansion of its proprietary immuno-oncology product pipeline. The company is currently using its cell-free protein synthesis technology to develop new ...
Roche and Prothena have agreed to jointly develop and commercialize new antibodies that target alpha-synuclein, including PRX002, Prothena's monoclonal antibody for the treatment of Parkinson's disease (PD). Currently, PRX002 is in ...
RayBiotech (RBI) has executed a master services and supply agreement with the Proteomics and Metabolomics Core Facility of Colorado State University in Fort Collin, Colorado. Under the deal, RayBiotech will offer biomarker discovery and ...